Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $291.79 million. The enterprise value is $868.39 million.
Important Dates
The next confirmed earnings date is Wednesday, May 7, 2025, after market close.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
EBS has 54.34 million shares outstanding. The number of shares has increased by 3.52% in one year.
Current Share Class | 54.34M |
Shares Outstanding | 54.34M |
Shares Change (YoY) | +3.52% |
Shares Change (QoQ) | -2.52% |
Owned by Insiders (%) | 2.53% |
Owned by Institutions (%) | 63.70% |
Float | 52.96M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 77.62 |
PS Ratio | 0.27 |
Forward PS | 0.29 |
PB Ratio | 0.60 |
P/TBV Ratio | n/a |
P/FCF Ratio | 8.15 |
P/OCF Ratio | 4.97 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 16.26, with an EV/FCF ratio of 24.26.
EV / Earnings | n/a |
EV / Sales | 0.83 |
EV / EBITDA | 16.26 |
EV / EBIT | n/a |
EV / FCF | 24.26 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 1.40.
Current Ratio | 3.69 |
Quick Ratio | 1.56 |
Debt / Equity | 1.40 |
Debt / EBITDA | 12.66 |
Debt / FCF | 18.89 |
Interest Coverage | -0.74 |
Financial Efficiency
Return on equity (ROE) is -33.67% and return on invested capital (ROIC) is -2.43%.
Return on Equity (ROE) | -33.67% |
Return on Assets (ROA) | -2.03% |
Return on Invested Capital (ROIC) | -2.43% |
Return on Capital Employed (ROCE) | -4.25% |
Revenue Per Employee | $1.16M |
Profits Per Employee | -$211,778 |
Employee Count | 900 |
Asset Turnover | 0.65 |
Inventory Turnover | 2.09 |
Taxes
In the past 12 months, EBS has paid $47.70 million in taxes.
Income Tax | 47.70M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +134.50% in the last 52 weeks. The beta is 2.15, so EBS's price volatility has been higher than the market average.
Beta (5Y) | 2.15 |
52-Week Price Change | +134.50% |
50-Day Moving Average | 5.90 |
200-Day Moving Average | 8.54 |
Relative Strength Index (RSI) | 54.42 |
Average Volume (20 Days) | 1,249,402 |
Short Selling Information
The latest short interest is 8.97 million, so 16.51% of the outstanding shares have been sold short.
Short Interest | 8.97M |
Short Previous Month | 8.14M |
Short % of Shares Out | 16.51% |
Short % of Float | 16.94% |
Short Ratio (days to cover) | 6.12 |
Income Statement
In the last 12 months, EBS had revenue of $1.04 billion and -$190.60 million in losses. Loss per share was -$3.60.
Revenue | 1.04B |
Gross Profit | 375.40M |
Operating Income | -52.20M |
Pretax Income | -578.10M |
Net Income | -190.60M |
EBITDA | 53.40M |
EBIT | -52.20M |
Loss Per Share | -$3.60 |
Full Income Statement Balance Sheet
The company has $99.50 million in cash and $676.10 million in debt, giving a net cash position of -$576.60 million or -$10.61 per share.
Cash & Cash Equivalents | 99.50M |
Total Debt | 676.10M |
Net Cash | -576.60M |
Net Cash Per Share | -$10.61 |
Equity (Book Value) | 482.80M |
Book Value Per Share | 8.89 |
Working Capital | 436.30M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $58.70 million and capital expenditures -$22.90 million, giving a free cash flow of $35.80 million.
Operating Cash Flow | 58.70M |
Capital Expenditures | -22.90M |
Free Cash Flow | 35.80M |
FCF Per Share | $0.66 |
Full Cash Flow Statement Margins
Gross margin is 35.97%, with operating and profit margins of -5.00% and -18.26%.
Gross Margin | 35.97% |
Operating Margin | -5.00% |
Pretax Margin | -13.69% |
Profit Margin | -18.26% |
EBITDA Margin | 5.12% |
EBIT Margin | -5.00% |
FCF Margin | 3.43% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.52% |
Shareholder Yield | -3.52% |
Earnings Yield | -65.32% |
FCF Yield | 12.27% |
Dividend Details Analyst Forecast
The average price target for EBS is $14.33, which is 166.85% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $14.33 |
Price Target Difference | 166.85% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 11.33% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 1.01 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.01 |
Piotroski F-Score | 5 |